Eris Lifesciences Limited (ERIS.BO)
INR 1384.5
(1.5%)
INR 1384.5
(1.5%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.18 Billion INR | 14.61% |
| 2022 | 4.29 Billion INR | -0.43% |
| 2021 | 4.31 Billion INR | 8.88% |
| 2020 | 3.96 Billion INR | 20.97% |
| 2019 | 3.27 Billion INR | 5.31% |
| 2018 | 3.1 Billion INR | 4.58% |
| 2017 | 2.97 Billion INR | 20.54% |
| 2016 | 2.46 Billion INR | 59.97% |
| 2015 | 1.54 Billion INR | 45.3% |
| 2014 | 1.06 Billion INR | 12.39% |
| 2013 | 944.32 Million INR | 7.68% |
| 2012 | 876.96 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.84 Billion INR | 5.73% |
| 2024 Q1 | 1.74 Billion INR | 84.12% |
| 2023 Q2 | 1.39 Billion INR | 7.92% |
| 2023 Q4 | 945.31 Million INR | -29.45% |
| 2023 FY | 4.92 Billion INR | 14.61% |
| 2023 Q1 | 1.28 Billion INR | 53.83% |
| 2023 Q3 | 1.33 Billion INR | -3.64% |
| 2022 Q4 | 837.64 Million INR | -21.94% |
| 2022 FY | 4.29 Billion INR | -0.43% |
| 2022 Q3 | 1.07 Billion INR | -12.64% |
| 2022 Q2 | 1.22 Billion INR | 16.14% |
| 2022 Q1 | 1.05 Billion INR | 34.67% |
| 2021 Q1 | 1.12 Billion INR | 34.86% |
| 2021 Q3 | 1.04 Billion INR | -16.03% |
| 2021 FY | 4.31 Billion INR | 8.88% |
| 2021 Q2 | 1.24 Billion INR | 11.47% |
| 2021 Q4 | 785.34 Million INR | -25.09% |
| 2020 Q4 | 830.59 Million INR | -16.69% |
| 2020 Q1 | 950.42 Million INR | 53.67% |
| 2020 Q2 | 1.16 Billion INR | 22.35% |
| 2020 Q3 | 996.97 Million INR | -14.27% |
| 2020 FY | 3.96 Billion INR | 20.97% |
| 2019 Q3 | 725.49 Million INR | -29.76% |
| 2019 FY | 3.27 Billion INR | 5.31% |
| 2019 Q4 | 618.5 Million INR | -14.75% |
| 2019 Q2 | 1.03 Billion INR | 7.78% |
| 2019 Q1 | 958.29 Million INR | 52.9% |
| 2018 Q3 | 942.2 Million INR | -4.4% |
| 2018 FY | 3.1 Billion INR | 4.58% |
| 2018 Q4 | 626.73 Million INR | -33.48% |
| 2018 Q2 | 985.6 Million INR | 16.23% |
| 2018 Q1 | 848 Million INR | 21.2% |
| 2017 Q4 | 699.69 Million INR | -12.74% |
| 2017 FY | 2.97 Billion INR | 20.54% |
| 2017 Q1 | 736.8 Million INR | 82.41% |
| 2017 Q2 | 989.41 Million INR | 34.28% |
| 2017 Q3 | 801.89 Million INR | -18.95% |
| 2016 Q3 | 719.3 Million INR | -8.2% |
| 2016 FY | 2.46 Billion INR | 59.97% |
| 2016 Q4 | 403.92 Million INR | -43.85% |
| 2016 Q2 | 783.56 Million INR | 6.85% |
| 2016 Q1 | 733.36 Million INR | 0.0% |
| 2015 FY | 1.54 Billion INR | 45.3% |
| 2014 FY | 1.06 Billion INR | 12.39% |
| 2013 FY | 944.32 Million INR | 7.68% |
| 2012 FY | 876.96 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.032% |
| NATCO Pharma Limited | 25.96 Billion INR | 80.041% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -12.459% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1978.916% |
| Achyut Healthcare Limited | 4.43 Million INR | -116657.999% |
| Ajanta Pharma Limited | 19.67 Billion INR | 73.667% |
| Alkem Laboratories Limited | 19.46 Billion INR | 73.375% |
| Alpa Laboratories Limited | 184.49 Million INR | -2708.566% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 10.01% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -201.701% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 87.722% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -320.935% |
| Brooks Laboratories Limited | 14.44 Million INR | -35784.488% |
| Divi's Laboratories Limited | 33.08 Billion INR | 84.336% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.349% |
| FDC Limited | 2.98 Billion INR | -73.522% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 20.31% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 42.292% |
| Granules India Limited | 6.81 Billion INR | 23.985% |
| Gufic Biosciences Limited | 1.32 Billion INR | -289.629% |
| Hester Biosciences Limited | 364.81 Million INR | -1320.389% |
| Indoco Remedies Limited | 1.29 Billion INR | -300.892% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -17.219% |
| Ipca Laboratories Limited | 7.98 Billion INR | 35.071% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -919.763% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 3509.991% |
| Lasa Supergenerics Limited | -458 Million INR | 1231.368% |
| Laurus Labs Limited | 3.94 Billion INR | -31.229% |
| Lupin Limited | 28.04 Billion INR | 81.523% |
| Mankind Pharma Limited | 21.51 Billion INR | 75.919% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -5066.221% |
| Megasoft Limited | -121.1 Million INR | 4378.736% |
| Piramal Pharma Limited | 4.55 Billion INR | -13.712% |
| RPG Life Sciences Limited | 2.29 Billion INR | -126.049% |
| Sigachi Industries Limited | 1.47 Billion INR | -251.566% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 225.921% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -809.527% |
| Windlas Biotech Limited | 1.29 Billion INR | -298.934% |
| ZIM Laboratories Limited | 253.82 Million INR | -1941.422% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 87.979% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -85.991% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -1032.507% |
| Bal Pharma Limited | 233.9 Million INR | -2115.272% |
| Strides Pharma Science Limited | 5.22 Billion INR | 0.844% |
| Venus Remedies Limited | 534.65 Million INR | -869.178% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -65.65% |
| Nectar Lifesciences Limited | 923.8 Million INR | -460.91% |
| Shilpa Medicare Limited | 1.36 Billion INR | -279.26% |
| Aarti Drugs Limited | 7.14 Billion INR | 27.515% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -224.507% |
| Suven Life Sciences Limited | -1.22 Billion INR | 522.714% |
| Ind-Swift Limited | 1.22 Billion INR | -322.665% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 63.721% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 234.489% |
| Themis Medicare Limited | 392.58 Million INR | -1219.884% |
| Hikal Limited | 32.11 Million INR | -16037.403% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.547% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -727.09% |
| Wockhardt Limited | -670 Million INR | 873.391% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 0.14% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -57038.509% |
| Neuland Laboratories Limited | 5.31 Billion INR | 2.564% |
| Morepen Laboratories Limited | 4.17 Billion INR | -24.148% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2390.613% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -18771.44% |